Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading Update

4 Apr 2016 07:00

RNS Number : 9656T
First Derivatives PLC
04 April 2016
 

4 April 2016

 

First Derivatives plc

("FD" or the "Group")

 

Trading Update

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces continued strong trading in the second half of its financial year to 29 February 2016. As a result the Board now expects the financial performance for the full year to be comfortably ahead of current consensus forecasts of £109.5m of revenue and £22.1m of EBITDA.

 

Consulting

Consulting revenue continued to grow strongly in the second half driven by the Group's high level of contracted revenue and a number of important new customer wins. This included a number of projects where FD is to act as a strategic partner to assist major investment banks with change programmes. This is in line with our business model under which we seek to grow these initial wins into multi-year assignments.

 

Software

We continue to see strong demand in our traditional financial services market across our range of software products, signing a record number of contracts in the second half of our financial year. Due to the annual recurring nature of our software license contracts the full impact of these wins will be reflected in the financial year ended February 2017. Outside financial services, the Group continues to make good progress with potential customers and partners for its Kx technology products especially for digital marketing and sensor analytics applications.

 

 

Brian Conlon, Chief Executive Officer of FD, commented: "We have made strong progress over the course of the past year and are well placed to continue to do so. In consulting our increasing scale and breadth of expertise is enabling us to get involved earlier in the change lifecycle within our clients, leading to deeper and more strategic relationships. In software, our market-leading capability in analysing large volumes of data in real time is increasingly understood and as a result we have experienced an acceleration of contract wins during the past year. We look forward to updating shareholders further when we announce our full year results."

 

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUAOVRNNASRAR
Date   Source Headline
9th May 20257:00 amRNSForm 8.3 - FD Technologies plc
8th May 20253:26 pmRNSForm 8.3 - FD Technologies PLC
8th May 20253:22 pmPRNForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20252:49 pmRNSForm 8.3 FD TECHNOLOGIES PLC
8th May 20251:51 pmRNSForm 8.3 - FD TECHNOLOGIES PLC
8th May 202511:24 amRNSForm 8.3 - FD Technologies PLC
8th May 202511:13 amRNSForm 8.5 (EPT/RI) - FD Technologies plc
8th May 202510:02 amRNSForm 8.5 (EPT/NON-RI) FD Technologies plc
8th May 20259:53 amGNWForm 8.5 (EPT/RI) - FD Technologies Plc
8th May 20257:00 amRNSRECOMMENDED ACQUISITION OF FD TECHNOLOGIES PLC
7th May 202511:26 amRNSStatement regarding Possible Offer
16th Apr 20257:44 amRNSHolding(s) in Company
11th Apr 20251:25 pmRNSIssue of Equity
2nd Apr 20258:49 amRNSIssue of Equity
25th Mar 20257:00 amRNSTrading Statement
7th Mar 20259:24 amRNSHolding(s) in Company
4th Feb 20253:57 pmRNSIssue of Equity
4th Feb 20252:45 pmRNSHolding(s) in Company
3rd Feb 20252:36 pmRNSHolding(s) in Company
3rd Feb 202510:19 amRNSHolding(s) in Company
31st Jan 20254:01 pmRNSHolding(s) in Company
30th Jan 20252:09 pmRNSHolding(s) in Company
24th Jan 20257:00 amRNSTENDER OFFER RESULTS AND TOTAL VOTING RIGHTS
20th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 20252:20 pmRNSRESULTS OF GENERAL MEETING
8th Jan 20251:36 pmRNSHolding(s) in Company
8th Jan 20257:00 amRNSIssue of Equity
19th Dec 20245:00 pmRNSPublication of Circular Notice of GM
19th Dec 20247:00 amRNSProposed Tender Offer
13th Dec 20244:54 pmRNSIssue of Equity
13th Dec 20247:00 amRNSNotification of Long-Term Incentive Award to PDMR
3rd Dec 20247:00 amRNSCOMPLETION OF DIVESTMENT OF FIRST DERIVATIVE
26th Nov 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSProposed Divestment - Satisfaction of Conditions
11th Nov 20244:22 pmRNSNotice of Results
7th Nov 20248:54 amRNSHolding(s) in Company
24th Oct 202412:37 pmRNSResult of General Meeting
8th Oct 20245:00 pmRNSPublication of Circular and Notice of GM
8th Oct 20242:35 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSProposed Divestment
5th Sep 20242:39 pmRNSHolding(s) in Company
1st Aug 20248:43 amRNSTotal Voting Rights
18th Jul 20244:45 pmRNSResult of AGM
9th Jul 20241:56 pmRNSHolding(s) in Company
4th Jul 202410:36 amRNSHolding(s) in Company
2nd Jul 20244:30 pmRNSIssue of Equity
2nd Jul 20242:17 pmRNSHolding(s) in Company
1st Jul 20245:39 pmRNSPDMR Notice and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.